These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11681537)

  • 1. Preventing diabetic nephropathy: an audit.
    Hansen HP; Lund SS; Rossing P; Tarnow L; Nielsen FS; Jensen T; Parving HH
    Scand J Clin Lab Invest; 2001; 61(6):471-7. PubMed ID: 11681537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prevention of diabetic nephropathy: an audit.
    Schjoedt KJ; Hansen HP; Tarnow L; Rossing P; Parving HH
    Diabetologia; 2008 Jun; 51(6):956-61. PubMed ID: 18385971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM; McGill JB; Gans DJ
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors.
    Vilarrasa N; Soler J; Montanya E
    Acta Diabetol; 2005 Jun; 42(2):87-94. PubMed ID: 15944842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Hermans MP; Brichard SM; Colin I; Borgies P; Ketelslegers JM; Lambert AE
    Am J Med; 1992 Apr; 92(4B):102S-107S. PubMed ID: 1580274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
    Brichard SM; Santoni JP; Thomas JR; van de Voorde K; Ketelslegers JM; Lambert AE
    Diabete Metab; 1990; 16(1):30-6. PubMed ID: 2185055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
    Mathiesen ER; Hommel E; Giese J; Parving HH
    BMJ; 1991 Jul; 303(6794):81-7. PubMed ID: 1860008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy.
    Nishimura M; Sasaki T; Ohishi A; Oishi M; Kono S; Totani Y; Kato Y; Noto Y; Misaki S; Higashi K; Shimada F; Wakasugi H; Inoue K; Hoshiyama Y; Yamada K
    Clin Nephrol; 2001 Aug; 56(2):96-103. PubMed ID: 11522101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary prevention of diabetic nephropathy].
    Trevisan R
    G Ital Nefrol; 2012; 29 Suppl 58():S49-53. PubMed ID: 23229603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
    Poulsen PL
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy.
    Sato A; Tabata M; Hayashi K; Saruta T
    Clin Exp Nephrol; 2003 Sep; 7(3):215-20. PubMed ID: 14586718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ACE inhibitors and early diabetic nephropathy].
    Bangstad HJ; Hartmann A; Berg TJ; Hanssen KF
    Tidsskr Nor Laegeforen; 1995 Oct; 115(24):3039-41. PubMed ID: 7570536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.